Abstract
Objectives
We consider the followingcomparative effectiveness scenario. There are two treatments for a particular medical condition: a randomized experiment has demonstrated mediocre effectiveness for the first treatment, while a non-randomized study of the second treatment reports a much higher success rate. On what grounds might one justifiably prefer the second treatment over the first treatment, given only the information from those two studies, including design details? This situation occurs in reality and warrants study.
Methods
We consider a particular example involving studies of treatments for Crohn's disease. In order to help resolve these cases of asymmetric evidence, we make three contributions and apply them to our example.
Results
First, we demonstrate the potential to improve success rates above those found in a randomized trial, given heterogeneous effects. Second, we prove that deliberate treatment assignment can be more efficient than randomization when study results are to be transported to formulate an intervention policy on a wider population. Third, we provide formal conditions under which a temporal-discontinuity design approximates a randomized trial, and we introduce a novel design parameter to inform researchers about the strength of that approximation.
Conclusions
Overall, our results indicate that while randomization certainly provides special advantages, other study designs such as temporal-discontinuity designs also have distinct advantages, and can produce valuable evidence that informs treatment decisions and intervention policy.
Acknowledgments
Thank you to the anonymous reviewers who provided constructive feedback while reviewing this article. Thank you to Samuel Whitlock for conceiving and sharing the idea to efficiently assign treatments opposite to preferences.
-
Research ethics: Not applicable.
-
Informed consent: Not applicable.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Use of Large Language Models, AI and Machine Learning Tools: None declared.
-
Competing interests: The authors state no conflict of interest.
-
Research funding: None declared.
-
Data availability: Not applicable.
Appendix A: Mathematical proofs
Define
and restate the optimization problem in (1), without the optional constraint, and only the U objective function, as
In (14) the variables are (s, t, u, v), and in (14a) the objective function to be maximized is (s + u + v) while the objective function to be minimized is t, and the constraints are described on lines (14b), (14c), (14d), and (14e). By adding (14d) and (14e) we obtain
Subtracting (15) from (14c) results in
Reasoning from (16) and (14b), to minimize t we push s to its minimum and set
resulting in
From there via (14a) we obtain
By symmetry we obtain
Denote the proportion of the population that is affected by the treatment with
If α is known then the equation in (19) is an optional constraint for the problem described in (14). Adding (16) and (19) results in
from which we obtain
Likewise,
Given (r j , r k ) the function U(α) linearly maps its domain [|r j − r k |, min{r j + r k , 1}] (see (18)) onto a space of success rates ranging from max{r j , r k } up to min{r j + r k , (r j + r k + 1)/2, 1}=min{r j + r k , 1}, and the function L(α) linearly maps its similar domain [|(1 − r j ) − (1 − r k )|, min{(1 − r j ) + (1 − r k ), 1}] onto a space of success rates ranging from 1 − max{1 − r j , 1 − r k } down to 1 − min{(1 − r j ) + (1 − r k ), ((1 − r j ) + (1 − r k ) + 1)/2, 1}=1 − min{(1 − r j ) + (1 − r k ), 1}.
Appendix B: Discontinuity designs
Causal inference from observational data is a challenging problem. Natural experiments are one way to approach the problem. In particular, the methodology of Eckles et al. [30] is ideal, assuming an infinite population. They describe noise-induced randomization with a discontinuity design. There is a measured running variable Z=U + ϵ, where U is the real latent variable and ϵ is measurement noise. Treatment is assigned to those individuals with Z≥c for some cutoff value c and withheld from those individuals with Z<c. For small δ>0 we may restrict our attention to the sub population of individuals with Z ∈ (c − δ, c + δ). In the limit as δ → 0 treatment assignment is haphazard and in most circumstances it is therefore reasonable to conclude that all covariates are balanced and that causal inference is warranted.
An example will provide context and clarity. We adapt the methodology and notation of Eckles et al. [30] and apply it to the similar study of low birth weight infants conducted by Almond et al. [41]. The threshold of very low birth weight is c=1500 g. Infants born below the threshold are treated with intensive care, while infants born above the threshold are treated with standard care. It has been observed that infants born with birth weights just above 1,500 g have an infant mortality rate of approximately 5.5 %, while infants born with birth weights just below 1,500 g have an infant mortality rate of approximately 4.5 %[41]. Ideally, we have Z=U + ϵ where Z is the measured birth weight, U is the actual birth weight, and ϵ is exogenous measurement error. The latent variable U is a potential confounder. However, provided with a large enough population, on the sub population of infants with Z ∈ (c − δ, c + δ), in the limit as δ → 0, it may be reasonable to conclude that each strata of U will be equally balanced above and below c. With exogenous noise ϵ and treatment actively assigned from Z<c where Z=U + ϵ, we conclude that balance of U implies balance of all unmeasured covariates thus warranting causal inference from this noise-induced natural experiment.
It is worth discussing a subtle point relating to that warrant for causal inference from a natural experiment. If a single treatment were not actively assigned by an experimenter with control over the situation then we would not be able to conclude that all unmeasured covariates were balanced. Suppose for instance in the context of a natural, natural experiment [42] nature assigns multiple exposures. Consider as the treatment the primary exposure, but note that there is no way to know whether nature balanced the secondary exposures or not. This subtle point is discussed in further detail in ([37]; Section 5.2). It is related to the stable unit treatment value assumption ([43]; p. 10) and also the exclusion restriction ([44]; Section 3.2). Similar concerns about compound treatments arise in randomized experiments [45].
The noise-induced discontinuity design is a clever approach, but its results are not as compelling as the results of an actual experiment conducted on a representative sample of a well defined population. The problem becomes apparent when it is realized that the noise-induced discontinuity design requires conditioning on the results of a noisy process. Recall how Z=U + ϵ. Suppose continuous probability density functions h and g for U and ϵ, respectively. The probability density function h represents the population distribution of U values. The probability function g represents exogenous measurement error, assumed to be independent and identically distributed across individuals. The sub population of individuals with Z=c have a U distribution with a density function proportional to h(u)g(u − c). If we assume relatively small variance of the noise then h(u) is roughly constant near c and conditional on Z=c we have a distribution of U values with probability density function approximately equal to g(u − c). For instance, if the measurement noise is Gaussian then we have a warrant for causal inference on a sub population of individuals with U values normally distributed about the cutoff c. But that is not a representative sample of any sub population well defined from U. If we allow heterogeneous causal effects that depend on U then our causal inference could be biased unless the noise term is uniformly distributed.
This is a subtle point worth restating in the language of our example involving low birth weight infants. Yes, we can conduct causal inference; we can conclude that the treatment of intensive care provided to very low birth weight infants saved lives. No, we can not establish an intervention policy on a well defined sub population and estimate the average effect of our intervention, if the noise distribution is anything but uniform. We can’t say for example that intensive care saves approximately 1 % of infants with actual birth weights between 1,499 and 1,501 g, because there are alternate explanations on that particular sub population. It could be for example with Gaussian noise that the treatment of intensive care saved lives on the over sampled segment right near the cutoff of c=1500 but lost lives on the under sampled segments slightly further away from the cutoff near c=1499 g and c=1501 g. That scenario could be consistent with both a) the observed data that arose from a non-representative sample conditional on Z which contains noise and b) a smaller or non-existent average treatment effect on that sub population with 1499<u<1501, depending on the variance of the noise; see Figure 1. While a continuity or monotonicity of effects argument could be made, the thought experiment just described in this section reveals the importance of a well-defined population for intervention policy.

With Gaussian noise we observe a Gaussian distribution of U values conditional on Z=c=1500 which could result in an over selection of individuals who benefit from treatment (indicated with plus symbols in the plot) and an under selection of individuals who are harmed by treatment (indicated with minus symbols in the plot), warranting causal inference on the sub population with 1499<u<1501 while the average treatment effect on that same sub population is zero, limiting the effectiveness of any policy recommendation for the treatment across the whole sub population.
Appendix C: Conditional interventions
Pearl [46] represents interventions with the “do operator”. Within that framework an intervention is a “hypothetical situation in which treatment … is administered uniformly to the population” [46]. That definition of an intervention means that all individuals of a population have their treatment variable value set to the same prescribed value. Those individuals within the population whose treatment variable status was already at that prescribed value remain unaffected by such an intervention.
However, commenting on the use of causal diagrams for empirical research, Imbens and Rubin [47] have written the following.
Important subject-matter information is not conveniently represented by conditional independence in models with independent and identically distributed random variables. Suppose that, when a person’s health status is ’good’, there is no effect of a treatment on a final health outcome, but, when a person’s health status is ’sick’, there is an effect of this treatment, so there is dependence of final health status on treatment received conditional on initial health status. Although the available information is clearly relevant for the analysis, its incorporation, although immediate using potential outcomes, is not straightforward using graphical models.
There are graphical models that unify causal graphs and potential outcomes 48], [49], [50], [51, but here we will utilize potential outcomes notation.
Merriam-Webster’s dictionary defines a medical intervention as an “act of interfering with the outcome or course especially of a condition or process (as to prevent harm or improve functioning)” [52]. We emphasize that an intervention is an act of interfering, and we proceed to define conditional interventions as follows, so as to preclude consideration of the contradictory idea of intervening on individuals who do what they already planned to do.
Consider those individuals who plan on treatment X=x. An intervention conditional on x is the act of interfering and assigning X=(x + k), for some k≠0, to each individual who plans on treatment X=x. This is the same as Pearl’s definition previously described but applied only to individuals with X=x. However, we conceptualize this conditional intervention as doing the change k rather than doing the changed treatment value x + k. Conditional interventions can be applied to sub populations who would benefit, and the notation we just introduced helps to describe a planned intervention on individuals at various and specific times. When an individual, e.g. a person, is repeatedly measured at different points in time, it is recommended to consider the measurements as arising from different experimental units [43]. The simplest case of a conditional intervention arises in a cross sectional study with a binary treatment indicator X=0 for control and X=1 for treatment. In that simplest case we may apply an intervention of k=1 to those who prefer control and an intervention of k=−1 to those who prefer the treatment.
Suppose that X causes Y and we have observed the data of Table 1. The causal definition of no-confounding is P(y|do(x))=P(y|x) [53]. In potential outcomes notation, for x=2, the causal definition of no-confounding asserts that E(Y x=2)=E(Y|x=2), which is 1/2 in Table 1. The causal definition of no-confounding is satisfied. However, we could have E(Y x=2|x=0)=0 and E(Y x=2|x=1)=1, so the causal definition of no-confounding is technically still satisfied, but there is clearly causality apparent in the conditional, potential outcomes, and no association in the observed data. This simple example is related to what has been described as unfaithfulness of a population to a causal graph ([54]; Section 4). To avoid the assumption of faithfulness it is therefore reasonable to introduce a causal definition of conditional no-confounding to pair with our definition of conditional interventions. Basically, conditional no-confounding means E(Y x+k |x)=E(Y|x + k). We can condition on more than just the treatment variable X, as theoretically considered implicitly in the formulation of the constrained optimization problem in (1).
Hypothetical, observed data on categorical variables X and Y showing relative frequencies and no association between X and Y.
X=0 | X=1 | X=2 | |
---|---|---|---|
Y = 1 | 1/6 | 1/6 | 1/6 |
Y = 0 | 1/6 | 1/6 | 1/6 |
References
1. Chiba, M, Tsuji, T, Nakane, K, Tsuda, S, Ishii, H, Ohno, H, et al.. Induction with infliximab and a plant-based diet as first-line (ipf) therapy for crohn disease: a single-group trial. Perm J 2017;21. https://doi.org/10.7812/tpp/17-009.Search in Google Scholar PubMed PubMed Central
2. Colombel, JF, Sandborn, WJ, Reinisch, W, Mantzaris, GJ, Kornbluth, A, Rachmilewitz, D, et al.. Infliximab, azathioprine, or combination therapy for crohn’s disease. N Engl J Med 2010;362:1383–95. https://doi.org/10.1056/nejmoa0904492.Search in Google Scholar PubMed
3. Jongsma, MME, Aardoom, MA, Cozijnsen, MA, van Pieterson, M, de Meij, T, Groeneweg, M, et al.. First-line treatment with infliximab versus conventional treatment in children with newly diagnosed moderate-to-severe crohn’s disease: an open-label multicentre randomised controlled trial. Gut 2020;71:34–42. https://doi.org/10.1136/gutjnl-2020-322339.Search in Google Scholar PubMed PubMed Central
4. Sands, BE, Irving, PM, Hoops, T, Izanec, JL, Gao, LL, Gasink, C, et al.. Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active crohn’s disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trial. Lancet 2022;399:2200–11. https://doi.org/10.1016/s0140-6736(22)00688-2.Search in Google Scholar PubMed
5. Alatab, S, Sepanlou, SG, Ikuta, K, Vahedi, H, Bisignano, C, Safiri, S, et al.. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30. https://doi.org/10.1016/s2468-1253(19)30333-4.Search in Google Scholar PubMed PubMed Central
6. Fisher, RA. Design of experiments. Edinburgh, Scotland: Oliver and Boyd; 1935.Search in Google Scholar
7. Rosenbaum, PR. Design of observational studies. Cham, Switzerland: Springer International Publishing; 2020.10.1007/978-3-030-46405-9Search in Google Scholar
8. Jones, DS, Podolsky, SH. The history and fate of the gold standard. Lancet 2015;385:1502–3. https://doi.org/10.1016/s0140-6736(15)60742-5.Search in Google Scholar
9. Murad, MH, Asi, N, Alsawas, M, Alahdab, F. New evidence pyramid. Evid Base Med 2016;21:125–7. https://doi.org/10.1136/ebmed-2016-110401.Search in Google Scholar PubMed PubMed Central
10. Gerstman, BB. There is no single gold standard study design (rcts are not the gold standard). Expet Opin Drug Saf 2023;22:267–70. https://doi.org/10.1080/14740338.2023.2203488.Search in Google Scholar PubMed
11. Lewis, JD, Sandler, RS, Brotherton, C, Brensinger, C, Li, H, Kappelman, MD, et al.. A randomized trial comparing the specific carbohydrate diet to a mediterranean diet in adults with crohn’s disease. Gastroenterology 2021;161:837–52.e9. https://doi.org/10.1053/j.gastro.2021.05.047.Search in Google Scholar PubMed PubMed Central
12. Li, F, Thomas, LE. Addressing extreme propensity scores via the overlap weights. Am J Epidemiol 2018;188:250–7. https://doi.org/10.1093/aje/kwy201.Search in Google Scholar PubMed
13. Li, F, Morgan, KL, Zaslavsky, AM. Balancing covariates via propensity score weighting. J Am Stat Assoc 2017;113:390–400. https://doi.org/10.1080/01621459.2016.1260466.Search in Google Scholar
14. Thistlethwaite, DL, Campbell, DT. Regression-discontinuity analysis: an alternative to the ex post facto experiment. J Educ Psychol 1960;51:309–17. https://doi.org/10.1037/h0044319.Search in Google Scholar
15. Schochet, PZ. Statistical power for regression discontinuity designs in education evaluations. J Educ Behav Stat 2009;34:238–66. https://doi.org/10.3102/1076998609332748.Search in Google Scholar
16. Chiba, M, Tsuji, T, Nakane, K, Tsuda, S, Ishii, H, Ohno, H, et al.. Induction with infliximab and a plant-based diet as first-line (ipf) therapy for crohn disease: a single-group trial. Perm J 2017;21. https://doi.org/10.7812/tpp/17-009.Search in Google Scholar
17. Kahneman, D, Lovallo, D. Timid choices and bold forecasts: a cognitive perspective on risk taking. Manag Sci 1993;39:17–31. https://doi.org/10.1287/mnsc.39.1.17.Search in Google Scholar
18. Heckman, JJ, Urzua, S, Vytlacil, E. Understanding instrumental variables in models with essential heterogeneity. Rev Econ Stat 2006;88:389–432. https://doi.org/10.1162/rest.88.3.389.Search in Google Scholar
19. Rutgeerts, P, Peeters, M, Hiele, M, Vantrappen, G, Pennincx, F, Aerts, R, et al.. Effect of faecal stream diversion on recurrence of crohn’s disease in the neoterminal ileum. Lancet 1991;338:771–4. https://doi.org/10.1016/0140-6736(91)90663-a.Search in Google Scholar PubMed
20. Marks, DJB, Rahman, FZ, Sewell, GW, Segal, AW. Crohn’s disease: an immune deficiency state. Clin Rev Allergy Immunol 2009;38:20–31. https://doi.org/10.1007/s12016-009-8133-2.Search in Google Scholar PubMed PubMed Central
21. Wiecek, M, Panufnik, P, Pomorska, K, Lewandowski, K, Rydzewska, G. Diet as therapeutic intervention in crohn’s disease. Gastroenterol Rev 2022;17:96–102. https://doi.org/10.5114/pg.2022.116376.Search in Google Scholar PubMed PubMed Central
22. Gao, X, Cao, Q, Cheng, Y, Zhao, D, Wang, Z, Yang, H, et al.. Chronic stress promotes colitis by disturbing the gut microbiota and triggering immune system response. Proceedings of the National Academy of Sciences 2018;115. https://doi.org/10.1073/pnas.1720696115.Search in Google Scholar PubMed PubMed Central
23. Furey, TS, Sethupathy, P, Sheikh, SZ. Redefining the ibds using genome-scale molecular phenotyping. Nat Rev Gastroenterol Hepatol 2019;16:296–311. https://doi.org/10.1038/s41575-019-0118-x.Search in Google Scholar PubMed PubMed Central
24. Lu, H, Cole, SR, Howe, CJ, Westreich, D. Toward a clearer definition of selection bias when estimating causal effects. Epidemiology 2022;33:699–706. https://doi.org/10.1097/ede.0000000000001516.Search in Google Scholar
25. Smith, LH, VanderWeele, TJ. Bounding bias due to selection. Epidemiology 2019;30:509–16. https://doi.org/10.1097/ede.0000000000001032.Search in Google Scholar
26. Chiba, M. Lifestyle-related disease in crohn’s disease: relapse prevention by a semi-vegetarian diet. World J Gastroenterol 2010;16:2484. https://doi.org/10.3748/wjg.v16.i20.2484.Search in Google Scholar PubMed PubMed Central
27. Rosenbaum, PR. Evidence factors in observational studies. Biometrika 2010;97:333–45. https://doi.org/10.1093/biomet/asq019.Search in Google Scholar
28. Colombel, JF, Sandborn, WJ, Reinisch, W, Mantzaris, GJ, Kornbluth, A, Rachmilewitz, D, et al.. Infliximab, azathioprine, or combination therapy for crohn’s disease. N Engl J Med 2010;362:1383–95. https://doi.org/10.1056/nejmoa0904492.Search in Google Scholar PubMed
29. Hausman, C, Rapson, DS. Regression discontinuity in time: considerations for empirical applications. Annu Rev Resour Econ 2018;10:533–52. https://doi.org/10.1146/annurev-resource-121517-033306.Search in Google Scholar
30. Eckles, D, Ignatiadis, N, Wager, S, Wu, H. Noise-induced randomization in regression discontinuity designs. arXiv preprint arXiv:2004.09458 2023. https://arxiv.org/abs/2004.09458.Search in Google Scholar
31. Cushing, K, Higgins, PDR. Management of crohn disease: a review. JAMA 2021;325:69. https://doi.org/10.1001/jama.2020.18936.Search in Google Scholar PubMed PubMed Central
32. Chiba, M, Nakane, K, Komatsu, M. Westernized diet is the most ubiquitous environmental factor in inflammatory bowel disease. Perm J 2019;23. https://doi.org/10.7812/tpp/18-107.Search in Google Scholar PubMed PubMed Central
33. Polack, FP, Thomas, SJ, Kitchin, N, Absalon, J, Gurtman, A, Lockhart, S, C4591001 Clinical Trial Group, et al.. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N Engl J Med 2020;383:2603–15.10.1056/NEJMoa2110345Search in Google Scholar PubMed PubMed Central
34. Herrera, CD. Ethics, deception, and ‘those milgram experiments. J Appl Philos 2001;18:245–56. https://doi.org/10.1111/1468-5930.00192.Search in Google Scholar PubMed
35. Chiba, M, Morita, N. Incorporation of plant-based diet surpasses current standards in therapeutic outcomes in inflammatory bowel disease. Metabolites 2023;13:332. https://doi.org/10.3390/metabo13030332.Search in Google Scholar PubMed PubMed Central
36. Hariton, E, Locascio, JJ. Randomised controlled trials – the gold standard for effectiveness research: study design: randomised controlled trials. BJOG: Int J Obstet Gynaecol 2018;125:1716. https://doi.org/10.1111/1471-0528.15199.Search in Google Scholar PubMed PubMed Central
37. Knaeble, B, Osting, B, Tshiaba, P. An asymptotic threshold of sufficient randomness for causal inference. Stat 2023;12. https://doi.org/10.1002/sta4.609.Search in Google Scholar
38. Zhang, Y, Ben-Michael, E, Imai, K Safe policy learning under regression discontinuity designs with multiple cutoffs. arXiv preprint arXiv:2208.13323 2023. https://arxiv.org/abs/2208.13323.Search in Google Scholar
39. Kasy, M, Sautmann, A. Adaptive experiments for policy research. VoxDev; 2021a. Available from: https://voxdev.org/topic/methods-measurement/adaptive-experiments-policy-research.Search in Google Scholar
40. Kasy, M, Sautmann, A. Adaptive treatment assignment in experiments for policy choice. Econometrica 2021b;89:113–32. https://doi.org/10.3982/ecta17527.Search in Google Scholar
41. Almond, D, Doyle, JJJ, Kowalski, AE, Williams, H. Estimating marginal returns to medical care: evidence from at-risk newborns. Q J Econ 2010;125:591–634. https://doi.org/10.1162/qjec.2010.125.2.591.Search in Google Scholar PubMed PubMed Central
42. Rosenzweig, MR, Wolpin, KI. Natural “natural experiments” in economics. J Econ Lit 2000;38:827–74. https://doi.org/10.1257/jel.38.4.827.Search in Google Scholar
43. Imbens, GW, Rubin, DB. Causal inference for statistics, social, and biomedical sciences. New York, NY, USA: Cambridge University Press; 2015.10.1017/CBO9781139025751Search in Google Scholar
44. Angrist, JD, Imbens, GW, Rubin, DB. Identification of causal effects using instrumental variables. J Am Stat Assoc 1996;91:444–55. https://doi.org/10.1080/01621459.1996.10476902.Search in Google Scholar
45. Hernán, MA, VanderWeele, TJ. Compound treatments and transportability of causal inference. Epidemiology 2011;22:368–77. https://doi.org/10.1097/ede.0b013e3182109296.Search in Google Scholar
46. Pearl, J. Causal inference in statistics: an overview. Stat Surv 2009a;3. https://doi.org/10.1214/09-ss057.Search in Google Scholar
47. Imbens, GW, Rubin, DB. Causal diagrams for empirical research. Biometrika 1995;82:694–5.10.1093/biomet/82.4.694Search in Google Scholar
48. Richardson, TS, Robins, JM. Single world intervention graphs (swigs): a unification of the counterfactual and graphical approaches to causality; 2013. Available at: https://www.stats.ox.ac.uk/~evans/uai13/Richardson.pdf.Search in Google Scholar
49. Malinsky, D, Shpitser, I, Richardson, T. A potential outcomes calculus for identifying conditional Path-Specific effects. Proc Mach Learn Res 2019;89:3080–8.Search in Google Scholar
50. Pearl, J. An introduction to causal inference. Int J Biostat 2010;6:7.10.2202/1557-4679.1203Search in Google Scholar PubMed PubMed Central
51. Alatab, S, Sepanlou, SG, Ikuta, K, Vahedi, H, Bisignano, C, Safiri, S, et al.. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol Hepatol 2020;5:17–30. https://doi.org/10.1016/s2468-1253(19)30333-4.Search in Google Scholar PubMed PubMed Central
52. Merriam-Webster. Merriam-Webster.com dictionary; 2023. Medical Definition. Available from: https://www.merriam-webster.com/dictionary/intervention.Search in Google Scholar
53. Pearl, J. Causality: models, reasoning, and inference. Cambridge, UK: Cambridge University Press; 2009b.10.1017/CBO9780511803161Search in Google Scholar
54. Scheines, R. An introduction to causal inference; 1997. Available from: https://kilthub.cmu.edu/articles/An_Introduction_to_Causal_Inference/6490904/1.Search in Google Scholar
© 2024 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Research Articles
- Using specific, validated vs. non-specific, non-validated tools to measure a subjective concept: application on COVID-19 burnout scales in a working population
- Linked shrinkage to improve estimation of interaction effects in regression models
- A study of a deterministic model for meningitis epidemic
- Population dynamic study of two prey one predator system with disease in first prey using fuzzy impulsive control
- Leveraging data from multiple sources in epidemiologic research: transportability, dynamic borrowing, external controls, and beyond
- Temporal discontinuity trials and randomization: success rates versus design strength
- Effect of designations of index date in externally controlled trials: an empirical example
Articles in the same Issue
- Research Articles
- Using specific, validated vs. non-specific, non-validated tools to measure a subjective concept: application on COVID-19 burnout scales in a working population
- Linked shrinkage to improve estimation of interaction effects in regression models
- A study of a deterministic model for meningitis epidemic
- Population dynamic study of two prey one predator system with disease in first prey using fuzzy impulsive control
- Leveraging data from multiple sources in epidemiologic research: transportability, dynamic borrowing, external controls, and beyond
- Temporal discontinuity trials and randomization: success rates versus design strength
- Effect of designations of index date in externally controlled trials: an empirical example